Amgen, Inc. (AMGN)
317.74
+0.36
(+0.11%)
USD |
NASDAQ |
Dec 12, 16:00
319.00
+1.26
(+0.40%)
After-Hours: 20:00
Amgen Accounts Payable (Quarterly): 2.838B for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 413.10M |
| Gilead Sciences, Inc. | 808.00M |
| Johnson & Johnson | 9.625B |
| Eli Lilly & Co. | 4.262B |
| Regeneron Pharmaceuticals, Inc. | 903.80M |